You are here

Article info

Article menu

Download PDFPDF

Review
Immune modulatory microRNAs in tumors, their clinical relevance in diagnosis and therapy

Authors

  • Christoforos Vaxevanis Institute for Medical Immunology, Martin Luther University Halle Wittenberg, Halle, Germany PubMed articlesGoogle scholar articles
  • Michael Bachmann Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany PubMed articlesGoogle scholar articles
  • Barbara Seliger Institute for Medical Immunology, Martin Luther University Halle Wittenberg, Halle, GermanyInstitute for Translational Immunology, Brandenburg Medical School Theodor Fontane, Brandenburg, GermanyFraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, GermanyInstitute of Translational Immunology, Faculty of Health Sciences Brandenburg, Brandenburg Medical School Theodor Fontane, Brandenburg, Germany PubMed articlesGoogle scholar articles

Citation

Vaxevanis C, Bachmann M, Seliger B
Immune modulatory microRNAs in tumors, their clinical relevance in diagnosis and therapy
Journal for ImmunoTherapy of Cancer 2024;12:e009774. doi: 10.1136/jitc-2024-009774
Online issue publication 
August 29, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.